Evaluating the Safety and Protective Efficacy of a Single Dose of the Live Attenuated Tetravalent Dengue Vaccine TV005 to Protect Against Infection With rDEN3Δ30
Clinical trial NCT02873260 · COMPLETED
Trial details
- NCT number
- NCT02873260
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-08-01
- Primary completion
- 2017-11-01
- Enrollment
- 48
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.